A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease
暂无分享,去创建一个
J. Farrar | S. Baker | T. Hien | N. Phu | D. Lalloo | J. Day | J. Campbell | Van-An Duong | N. H. Mai | D. Sinh | L. Chuong | P. T. Diep | Tran T H Chau | Ho D T Nghia
[1] J. Perfect,et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] P. Hsueh,et al. Disseminated Cryptococcus neoformans var. grubii infections in intensive care units , 2009, Epidemiology and Infection.
[3] S. Jaffar,et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] T. Steiner,et al. Dexamethasone in Cryptococcus gattii central nervous system infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] B. Wickes,et al. Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans , 2008, Antimicrobial Agents and Chemotherapy.
[6] A. Litvintseva,et al. Cryptococcus neoformans Strains and Infection in Apparently Immunocompetent Patients, China , 2008, Emerging infectious diseases.
[7] P. Hsueh,et al. Disseminated cryptococcosis in HIV-uninfected patients , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[8] S. Sungkanuparph,et al. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. , 2008, Japanese journal of infectious diseases.
[9] J. Kronstad,et al. The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest , 2008, Current infectious disease reports.
[10] J. Heitman,et al. First Contemporary Case of Human Infection with Cryptococcus gattii in Puget Sound: Evidence for Spread of the Vancouver Island Outbreak , 2007, Journal of Clinical Microbiology.
[11] Y. Chow,et al. Cryptococcus gattii Dispersal Mechanisms, British Columbia, Canada , 2007, Emerging infectious diseases.
[12] K. Ng,et al. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs , 2006, Mycoses.
[13] M. Pfaller,et al. Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004) , 2005, Journal of Clinical Microbiology.
[14] T. Boekhout,et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Netea,et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] J. Guarro,et al. In Vitro Antifungal Susceptibility of Cryptococcus gattii , 2004, Journal of Clinical Microbiology.
[17] L. Hoang,et al. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. , 2004, Journal of medical microbiology.
[18] N. White,et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial , 2004, The Lancet.
[19] P. Kazembe,et al. Antifungal Susceptibilities of Cryptococcus neoformans , 2004, Emerging infectious diseases.
[20] W. Meyer,et al. Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates , 2003, Emerging infectious diseases.
[21] C. Stephen,et al. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. , 2002, The Canadian veterinary journal = La revue veterinaire canadienne.
[22] R. M. Warren,et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] E. Fung,et al. Cryptococcosis: clinical and biological aspects. , 2000, Medical mycology.
[24] K. Byth,et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] Yee-Chun Chen,et al. Cryptococcal meningitis in non-HIV-infected patients. , 2000, QJM : monthly journal of the Association of Physicians.
[26] Y. C. Chen,et al. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. , 2000, Diagnostic microbiology and infectious disease.
[27] M. Saag,et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.
[28] Y. Coovadia,et al. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] L. Letenneur,et al. Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] F. Dromer,et al. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] D. Warrell,et al. Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. , 1996, QJM : monthly journal of the Association of Physicians.
[32] L. Letenneur,et al. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] D. Dunt,et al. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] T. Sorrell,et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Rex,et al. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates. , 1994, Diagnostic microbiology and infectious disease.
[36] R. Rozenbaum,et al. Clinical epidemiological study of 171 cases of cryptococcosis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] B. Currie,et al. Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. , 1993, Australian and New Zealand journal of medicine.
[38] R. Diasio,et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. , 1987, The New England journal of medicine.
[39] K. Kwon-Chung,et al. Epidemiologic differences between the two varieties of Cryptococcus neoformans. , 1984, American journal of epidemiology.
[40] K. Kwon-Chung,et al. Epidemiologic differences among serotypes of Cryptococcus neoformans. , 1977, American journal of epidemiology.
[41] J. Bennett,et al. Prognostic factors in cryptococcal meningitis. A study in 111 cases. , 1974, Annals of internal medicine.
[42] C. Stephen,et al. Cryptococcus gattii in Wildlife of Vancouver Island, British Columbia, Canada , 2006, Journal of wildlife diseases.
[43] S. Kiertiburanakul,et al. Cryptococcosis in human immunodeficiency virus-negative patients. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[44] D. Denning,et al. Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications , 2004, Mycopathologia.
[45] D. Warrell,et al. Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[46] D. Warrell,et al. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.